Print

Print



A 3-year PhD studentship is available from October 2011 in the Biochemistry Department at the University of Leicester on "Structural and functional studies on mitotic NIMA-related kinases". The student will be based jointly in the laboratories of Richard Bayliss ([log in to unmask]) and Andrew Fry ([log in to unmask]), and informal enquiries can be sent to either supervisor. NIMA-related kinases are key regulators of mitosis, centrosomes and microtubules, and are a major focus of both laboratories. The Bayliss and Fry laboratories are housed within the flagship Henry Wellcome Building on the main University campus and are served by state-of-the-art facilities in structural biology and fluorescence microscopy. This project will provide the student with an excellent grounding in cutting-edge biochemical and molecular cell biology techniques. Hard-working, independent- minded and enthusiastic students who can work well in a team are encouraged to apply.

For examples of our recent work relevant to the project see:
1)     Richards MW, O’Regan L, Mas-Droux C, Blot JMY, Cheung J, Hoelder S, Fry AM, Bayliss R. (2009) An auto-inhibitory tyrosine motif in the cell cycle-regulated Nek7 kinase is released through binding of Nek9. Mol. Cell. 36(4):560-70. 
2) O'Regan L, Fry AM. (2009). The Nek6 and Nek7 protein kinases are required for robust mitotic spindle formation and cytokinesis. Mol Cell Biol. 29(14):3975-90.

Project details:  http://www2.le.ac.uk/colleges/medbiopsych/research/studentships/research-studentships-2011/MBSP-11-02%20Bayliss.pdf
Bayliss lab website: http://web.mac.com/baylisslab
Fry lab website: http://www2.le.ac.uk/departments/biochemistry/staff/fry
Departmental website: http://www2.le.ac.uk/departments/biochemistry/research

Eligibility: these awards are open to all applicants, but International  applicants (i.e. non UK/EU nationals/permanent residents) will be required to pay the difference between the International Registration fee (approx £9,500 p/a)

The Institute of Cancer Research: Royal Cancer Hospital, a charitable Company Limited by Guarantee, Registered in England under Company No. 534147 with its Registered Office at 123 Old Brompton Road, London SW7 3RP.

This e-mail message is confidential and for use by the addressee only. If the message is received by anyone other than the addressee, please return the message to the sender by replying to it and then delete the message from your computer and network.